Remove BioTech Remove Medicare Remove Strategy Remove Telehealth
article thumbnail

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

Digital Health Global

The Relationship to TeleHealth 5.3.7 ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 The report’s depth and scope extend to detailed breakouts for 15 countries and four regions, highlighting the global nature of the infectious disease diagnostics market and its varied dynamics.

BioTech 88
article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

Here’s one of many looks into the issue , in which I’m quoted on scenarios for Gilead’s possible pricing strategies for remdesivir. In today’s pharma/biotech market, the “specialty” label is given to many therapies: for products addressing rare diseases, risk-management, and above all, high cost drugs.

BioTech 191
article thumbnail

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

The macro-strategy for Optum is that, in their mission-words, “health care should be equally available to everyone, when and how they want it. Integrating with the telehealth service Care on the Optum Store. There is one health care public policy issue that unites U.S.